Red Cross moves to dismiss US antitrust claims
MLex Summary: While Verax Biomedical may not agree with the decision, the American National Red Cross’ adoption of pathogen reduction technology didn't violate any antitrust laws, the Red Cross told a...To view the full article, register now.
Already a subscriber? Click here to view full article